Jubilant Ingrevia Ltd.
NSE: JUBLINGREAJubilant Ingrevia Ltd.: A 30-second snapshot
Jubilant Ingrevia (Chemicals) trades at ₹731.80, up 5.27% over 12 months and 8.97% over 3 months, with price above its 50-DMA (₹641.35) and 200-DMA (₹675.66). The company carries a debt-to-equity ratio of 26.51 — a significant outlier versus Chemicals peers — and has posted a 5-year earnings CAGR of -32.3% with a consistency score of 0. A quality score of 14 places it last among 6 peers in the sector.
P/E
43.4
Forward P/E
31.1
ROE
—
Debt / Equity
26.51
Profit Margin
+6.2%
Div. Yield
+0.7%
5Y ROE > 15%
1/5
5Y FCF > 0
2/5
Quality
25/100
News
3 headlines · 0 positive · 1 negative
Exchange Seeks Clarification From Jubilant Ingrevia After Surge in Trading Volume - TipRanks
TipRanks
Jubilant Ingrevia Schedules Q4FY26 Results Conference Call for May 26, 2026 - scanx.trade
scanx.trade
Jubilant Ingrevia Issues Clarification on Stock Volatility - InvestyWise
InvestyWise
Recent context
- ·In April 2026, the exchange sought clarification from Jubilant Ingrevia after a surge in trading volume; the company subsequently issued a formal clarification on the stock volatility — the nature of the underlying trigger is not detailed in available coverage.
- ·Q4FY26 results conference call has been scheduled for May 26, 2026; the outcome of those results will be the next material data point for profitability trend assessment.
- ·News corpus is sparse at 3 articles (total), limiting the ability to assess recent corporate developments, management commentary, or operational updates beyond the exchange query and results scheduling.
Strengths
- +Trailing PE of 43.45 contracts to a forward PE of 31.08, a 28% compression, suggesting the market is embedding expectations of earnings recovery into current pricing.
- +Price is currently 13.5% below its 52-week high and holds above both the 50-DMA (₹641.35) and 200-DMA (₹675.66), with nearest support at ₹694.80.
- +RSI of 60.26 is in neutral territory, with no extreme reading in either direction at the current price level.
- +At 43.45x trailing earnings, JUBLINGREA trades near the midpoint of its Chemicals peer range (Coromandel at 28.19x to Solar Industries at 93.60x), not at a sector premium on this one metric.
Weaknesses
- −D/E of 26.51 is a severe outlier in the Chemicals sector; peers including Pidilite Industries and Coromandel International operate at a fraction of this leverage, amplifying sensitivity to interest costs and refinancing risk.
- −5-year earnings CAGR of -32.3% and 5-year revenue growth of -0.5% reflect persistent multi-year contraction in both top-line and bottom-line, not a one-year anomaly.
- −Consistency score of 0 — with ROE above 15% in only 1 of tracked years and FCF positive in only 2 years — indicates that quality fundamentals have been absent for the majority of the observable history.
- −Quality score of 14 ranks JUBLINGREA 6th of 6 Chemicals peers, 11 points below the next-closest peer (PI Industries at 25) and 52 points below the sector leader (Pidilite Industries at 66).
Open questions
- ?Does the compression from trailing PE of 43.45 to forward PE of 31.08 reflect genuine analyst consensus on an earnings inflection, or does it reflect a low base from the current earnings trough?
- ?What is the composition of the D/E of 26.51 — short-term working capital debt versus long-term structural borrowing — and what does the interest coverage ratio look like relative to the current EBITDA margin?
- ?The exchange query following the trading volume surge was answered with a clarification from management; what specific trigger prompted the exchange query, and is there any material corporate development that preceded it?
- ?Given that FCF was positive in only 2 of tracked years and earnings have declined at -32.3% CAGR over 5 years, what structural changes in the business or industry would need to occur to return JUBLINGREA to consistent profitability?
Peer comparison: Chemicals
Ranks 6 of 6 on quality| Symbol | Name | P/E | ROE | Quality |
|---|---|---|---|---|
| JUBLINGREA | Jubilant Ingrevia Ltd.You're viewing | 43.4 | — | 14 |
| Industry avg | across 5 peers | 51.8 | +21.1% | 45 |
| PIDILITIND | Pidilite Industries Ltd. | 61.2 | +23.5% | 66 |
| SOLARINDS | Solar Industries India Ltd. | 93.6 | +31.3% | 61 |
| SRF | SRF Ltd. | 43.5 | +13.8% | 41 |
| COROMANDEL | Coromandel International Ltd. | 28.2 | +15.6% | 30 |
| PIIND | PI Industries Ltd. | 32.6 | — | 25 |
Technical state
Current price
₹731.80
SMA 50
₹641.35
SMA 200
₹675.66
RSI (14)
60.3 (neutral)
From 52w high
-13.5%
1Y return
+5.3%
3M return
+9.0%
50-DMA
Above
200-DMA
Above
Algorithmic support levels
Algorithmic resistance levels
Risk flags
- highDebt-to-equity of 26.51 is severely elevated for a Chemicals company; listed peers Pidilite Industries (qualityScore 66), SRF (qualityScore 41), and Coromandel (qualityScore 30) all operate with far lower leverage, making JUBLINGREA an outlier on balance-sheet risk within the cohort.
- high5-year earnings CAGR of -32.3% alongside a profit margin of 6.23%, FCF positive in only 2 of tracked years, ROE above 15% in only 1 year, and a consistency score of 0 together reflect persistent multi-year deterioration across profitability and cash-generation metrics.
- mediumQuality score of 14 ranks JUBLINGREA last (6th of 6) among Chemicals sector peers; the next-lowest peer score is 25 (PI Industries) and the highest is 66 (Pidilite Industries), placing JUBLINGREA well below the peer floor on composite quality.
- mediumNews corpus contains only 3 articles, below the threshold for reliable sentiment inference; one negative headline notes an exchange query after a surge in trading volume, and the company subsequently issued a clarification on stock volatility — both are governance-adjacent signals with limited follow-up data available.
- lowForward PE of 31.08 versus trailing PE of 43.45 implies market pricing of a meaningful earnings recovery, but 5-year earnings CAGR of -32.3% and 5-year revenue growth of -0.5% provide no historical basis for that assumption.
Cross-section contradictions
- Price is up 8.97% over 3 months and trades above both the 50-DMA (₹641.35) and 200-DMA (₹675.66), yet 5-year earnings CAGR is -32.3%, quality score is last of 6 Chemicals peers, and D/E stands at 26.51 — near-term price momentum is directionally opposed to the multi-year fundamental deterioration.
- 6 analysts cover the stock but consensus rating is null, leaving the directional view of active sell-side coverage unquantifiable.
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.
Fundamentals & technicals: refreshed 25 Jun 2026 · refreshed daily at 01:00 IST
AI synthesis (narrative, snapshot, strengths/weaknesses, peer ranking): generated 17 May 2026 · rotates through NIFTY 500 every ~5 days